References
- Díaz-Anzaldúa, A., Jobber, R., Riviere, J. B., Dion, Y., Lespérance, P., Richer, F., ... Rouleau, G. A. (2004).Tourette syndrome and dopaminergic genes: A family-based association study in the French Canadian founder population. Molecular Psychiatry, 9(3), 272–277.
- Gade, R., Muhleman, D., Blake, H., MacMurray, J., Johnson, P., Verde, R., … Comings, D. E. (1998). Correlation of length of VNTR alleles at the X-linked MAOA gene and phenotypic effect in Tourette syndrome and drug abuse. Molecular Psychiatry, 3(1), 50–60.
- Gokturk, C., Schultze, S., Nilsson, K. W., von Knorring, L., Oreland, L., & Hallman, J. (2008). Serotonin transporter (5-HTTLPR) and monoamine oxidase (MAOA) promoter polymorphisms in women with severe alcoholism. Archives of Women’s Mental Health, 11(5–6), 347–355.
- Grice, D. E., Leckman, J. F., Pauls, D. L., Kurlan, R., Kidd, K. K., Pakstis, A. J., … Gelernter, J. (1996). Linkage disequilibrium between an allele at the dopamine D4 receptor locus and Tourette syndrome, by the transmission-disequilibrium test. American Journal of Human Genetics, 59(3), 644–652.
- Kazuhiko, N., Yoshimoto, S., Noriyoshi, T., Yasuhide, I., Katsuaki, S., Ayyappan, A., … Norio, M. (2009). An association study of monoamine oxidase A (MAOA) gene polymorphism in methamphetamine psychosis. Neuroscience Letters, 455, 120–123.
- Lung, F. W., Tzeng, D. S., Huang, M. F., & Lee, M. B. (2011). Association of the MAOA promoter uVNTR polymorphism with suicide attempts in patients with major depressive disorder. BMC Medical Genetics, 12, 74.
- Ozelius, L., Hsu, Y. P., Bruns, G., Powell, J. F., Chen, S., Weyler, W., … Breakefield, X. O.. (1988). Human monoamine oxidase gene (MAOA): Chromosome position (Xp21-p11) and DNA polymorphism. Genomics, 3(1), 53–58.
- Pauls, D. L., Cohen, D. J., Heimbuch, R., Detlor, J., & Kidd, K. K. (1981). Familial pattern and transmission of Gilles de la Tourette syndrome and multiple tics. Archives of General Psychiatry, 38(10), 1091–1093.
- Price, R. A., Kidd, K. K., Cohen, D. J., Pauls, D. L., & Leckman, J. F. (1985). A twin study of Tourette syndrome. Archives of General Psychiatry, 42(8), 815–820.
- Robertson, M. M., Eapen, V., & Cavanna, A. E. (2009). The international prevalence, epidemiology, and clinical phenomenology of Tourette syndrome: A cross-cultural perspective. Journal of Psychosomatic Research, 67(6), 475–483.
- Sabol, S. Z., Hu, S., & Hamer, D. (1998). A functional polymorphism in the monoamine oxidase A gene promoter. Human Genetics, 103(3), 273–279.
- Sjoberg, R. L., Ducci, F., Barr, C. S., Newman, T. K., Dell’osso, L., Virkkunen, M., & Goldman, D. (2008). A non-additive interaction of a functional MAO-A VNTR and testosterone predicts antisocial behavior. Neuro- Psychopharmacology, 33(2), 425–430.
- Tarnok, Z., Ronai, Z., Gervai, J., Kereszturi, E., Gadoros, J., Sasvari-Szekely, M., & Nemoda, Z. (2007). Dopaminergic candidate genes in Tourette syndrome: Association between tic severity and 3′ UTR polymorphism of the dopamine transporter gene. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 144B(7), 900–905.
- Yoon, D. Y., Rippel, C. A., Kobets, A. J., Morris, C. M., Lee, J. E., Williams, P. N., … Singer, H. S. (2007). Dopaminergic polymorphisms in Tourette syndrome: Association with the DAT gene (SLC6A3). American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 144B(5), 605–610.
- Zsofia, N., Anna, S., & Maria, S. (2011, August). Psychopathological aspects of dopaminergic gene polymorphisms in adolescence and young adulthood. Neuroscience and Biobehavioral Reviews, 35(8), 1665–1686.